Non-invasive Diagnosis of Coronary Microvascular Disease: Pilot Study

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Microvascular Angina
Interventions
DIAGNOSTIC_TEST

Coronary microvascular disease testing during coronary angiography

During invasive coronary angiography, in addition to coronary angiography performed as per routine clinical care, participants will have angiographic testing for coronary microvascular disease using routine clinical procedures. This will consist of fractional flow reserve (FFR), coronary flow reserve, index of microvascular resistance and vasospasm provocation testing with acetylcholine (Ach).

DIAGNOSTIC_TEST

Cardiac magnetic resonance scan including exercise

Participants will undergo a cardiac magnetic resonance scan compromising 1) T1 mapping, 2) oxygenation-sensitive MRI and 3) perfusion imaging. All will be obtained at rest and during exercise using a step ergometer.

DIAGNOSTIC_TEST

Additional analysis of already acquired CT scan

Previously acquired CTCA images from the main research study will be transferred to Heartflow for computation of coronary blood volume.

Trial Locations (1)

Unknown

RECRUITING

Glenfield Hospital, University Hospitals of Leicester, Leicester

All Listed Sponsors
lead

University of Leicester

OTHER